Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart J Gallagher

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
The Journal of Investigative Dermatology|October 25, 2021
Repurposing Melanoma Chemotherapy to Activate Inflammasomes in the Treatment of BRAF/MAPK Inhibitor Resistant MelanomaFarzana Ahmed, Hsin-Yi Tseng, Antonio Ahn, et al.
Neoplasia (New York, N.Y.)|October 28, 2008
p16INK4a expression and absence of activated B-RAF are independent predictors of chemosensitivity in melanoma tumorsStuart J Gallagher, John F Thompson, James Indsto, et al.
Iscience|September 22, 2018
Marked Global DNA Hypomethylation Is Associated with Constitutive PD-L1 Expression in MelanomaAniruddha Chatterjee, Euan J Rodger, Antonio Ahn, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 2018
Anti-PD-1-induced high-grade hepatitis associated with corticosteroid-resistant T cells: a case reportHelen M McGuire, Elena Shklovskaya, Jarem Edwards, et al.
Pigment Cell & Melanoma Research|June 14, 2014
Control of NF-kB activity in human melanoma by bromodomain and extra-terminal protein inhibitor I-BET151Stuart J Gallagher, Branka Mijatov, Dilini Gunatilake, et al.
The Journal of Investigative Dermatology|June 7, 2014
The epigenetic regulator I-BET151 induces BIM-dependent apoptosis and cell cycle arrest of human melanoma cellsStuart J Gallagher, Branka Mijatov, Dilini Gunatilake, et al.
The Journal of Investigative Dermatology|May 4, 2020
EZH2 Cooperates with DNA Methylation to Downregulate Key Tumor Suppressors and IFN Gene Signatures in MelanomaJessamy Tiffen, Stuart J Gallagher, Fabian Filipp, et al.
International Journal of Cancer|December 7, 2017
HDAC inhibitors restore BRAF-inhibitor sensitivity by altering PI3K and survival signalling in a subset of melanomaStuart J Gallagher, Dilini Gunatilake, Kimberley A Beaumont, et al.
Oncotarget|June 19, 2015
Combining BET and HDAC inhibitors synergistically induces apoptosis of melanoma and suppresses AKT and YAP signalingAnja Heinemann, Carleen Cullinane, Ricardo De Paoli-Iseppi, et al.
Nature Communications|August 26, 2018
SIRT6 haploinsufficiency induces BRAF<sup>V600E</sup> melanoma cell resistance to MAPK inhibitors via IGF signallingThomas Strub, Flavia G Ghiraldini, Saul Carcamo, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
The Journal of Investigative Dermatology|October 25, 2021
Repurposing Melanoma Chemotherapy to Activate Inflammasomes in the Treatment of BRAF/MAPK Inhibitor Resistant MelanomaFarzana Ahmed, Hsin-Yi Tseng, Antonio Ahn, et al.
Neoplasia (New York, N.Y.)|October 28, 2008
p16INK4a expression and absence of activated B-RAF are independent predictors of chemosensitivity in melanoma tumorsStuart J Gallagher, John F Thompson, James Indsto, et al.
Iscience|September 22, 2018
Marked Global DNA Hypomethylation Is Associated with Constitutive PD-L1 Expression in MelanomaAniruddha Chatterjee, Euan J Rodger, Antonio Ahn, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 2018
Anti-PD-1-induced high-grade hepatitis associated with corticosteroid-resistant T cells: a case reportHelen M McGuire, Elena Shklovskaya, Jarem Edwards, et al.
Pigment Cell & Melanoma Research|June 14, 2014
Control of NF-kB activity in human melanoma by bromodomain and extra-terminal protein inhibitor I-BET151Stuart J Gallagher, Branka Mijatov, Dilini Gunatilake, et al.
The Journal of Investigative Dermatology|June 7, 2014
The epigenetic regulator I-BET151 induces BIM-dependent apoptosis and cell cycle arrest of human melanoma cellsStuart J Gallagher, Branka Mijatov, Dilini Gunatilake, et al.
The Journal of Investigative Dermatology|May 4, 2020
EZH2 Cooperates with DNA Methylation to Downregulate Key Tumor Suppressors and IFN Gene Signatures in MelanomaJessamy Tiffen, Stuart J Gallagher, Fabian Filipp, et al.
International Journal of Cancer|December 7, 2017
HDAC inhibitors restore BRAF-inhibitor sensitivity by altering PI3K and survival signalling in a subset of melanomaStuart J Gallagher, Dilini Gunatilake, Kimberley A Beaumont, et al.
Oncotarget|June 19, 2015
Combining BET and HDAC inhibitors synergistically induces apoptosis of melanoma and suppresses AKT and YAP signalingAnja Heinemann, Carleen Cullinane, Ricardo De Paoli-Iseppi, et al.
Nature Communications|August 26, 2018
SIRT6 haploinsufficiency induces BRAF<sup>V600E</sup> melanoma cell resistance to MAPK inhibitors via IGF signallingThomas Strub, Flavia G Ghiraldini, Saul Carcamo, et al.
Pageof 4